ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 60 filers reported holding ARALEZ PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $7,000 | -76.7% | 18,800 | -6.0% | 0.00% | -75.0% |
Q1 2018 | $30,000 | +7.1% | 20,000 | 0.0% | 0.01% | +14.3% |
Q4 2017 | $28,000 | -54.8% | 20,000 | -25.9% | 0.01% | -56.2% |
Q3 2017 | $62,000 | +72.2% | 27,000 | 0.0% | 0.02% | +166.7% |
Q2 2017 | $36,000 | -60.0% | 27,000 | -35.9% | 0.01% | -77.8% |
Q1 2017 | $90,000 | -56.7% | 42,100 | -10.6% | 0.03% | -60.9% |
Q4 2016 | $208,000 | -8.8% | 47,100 | 0.0% | 0.07% | +305.9% |
Q3 2016 | $228,000 | – | 47,100 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 2,737,140 | $9,033,000 | 7.18% |
DRILL CRAIG A | 584,600 | $1,929,000 | 3.80% |
ARMISTICE CAPITAL, LLC | 2,664,000 | $8,791,000 | 3.35% |
Healthcare Value Capital, LLC | 575,000 | $1,898,000 | 2.30% |
Tiger Legatus Capital Management, LLC | 1,500,000 | $4,950,000 | 1.50% |
Broadfin Capital, LLC | 4,106,990 | $13,553,000 | 1.32% |
Kavi Asset Management, LP | 313,627 | $1,035,000 | 0.83% |
Elk Creek Partners, LLC | 1,514,918 | $4,999,000 | 0.36% |
Par Capital Management | 6,400,000 | $21,120,000 | 0.35% |
Healthcare Value Capital, LLC | 75,000 | $248,000 | 0.30% |